Growth in contrast media driven by microbubbles

The global market for contrast media is expected to reach $5.44 billion by 2021, according to a Markets and Markets report. The growth is largely driven by the increase in microbubble usage, the fastest growing segment of contrast.

Microbubble imaging is used primarily in echocardiography and other ultrasound modalities, but it has potential for use in MRI and PET as well. There are a number of studies exploring nuclear applications for the bubbles, including measuring cerebral blood flow volume and central nervous system therapy.

The bubbles also find usage in treating strokes with thrombolysis, otherwise known as “clot busting."

Injectable contrast will remain the largest delivery method through 2021, owing to the rapid proliferation through blood vessels that enhances a clinician’s view of the brain, spine, liver or kidneys. Coming in second is oral contrast, mainly used in imaging the abdomen or pelvis.

Cardiovascular conditions will retain the largest share of contrast treatments when compared to other conditions. Advances in cath lab MRI and the designation of interventional cardiology as a recognized subspecialty by the Centers for Medicare & Medicaid Services have contributed to its favorable reimbursement status.

Read more about the report at Markets and Markets.

As a Senior Writer for TriMed Media Group, Will covers radiology practice improvement, policy, and finance. He lives in Chicago and holds a bachelor’s degree in Life Science Communication and Global Health from the University of Wisconsin-Madison. He previously worked as a media specialist for the UW School of Medicine and Public Health. Outside of work you might see him at one of the many live music venues in Chicago or walking his dog Holly around Lakeview.

Around the web

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.